Sorbent suspension reactor for extracorporeal detoxification in hepatic failure or drug overdose

ASAIO Journal

Volumn 50, Issue 6, 2004, Pages

  Ash, Stephen R ^a   Carr, David J ^b   Sullivan, T A ^b  

^a Greater Lafayette Health Systems   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; DIVINYLBENZENE; RESIN; STYRENE DERIVATIVE;

BLOOD TRANSFUSION; CAUSE OF DEATH; CONFERENCE PAPER; DETOXIFICATION; DRUG OVERDOSE; HEMODIALYSIS; HEMOFILTRATION; HEMOPERFUSION; HOSPITALIZATION; HUMAN; LIPID SOLUBILITY; LIVER FAILURE; MOLECULAR WEIGHT; PLASMAPHERESIS; TREATMENT OUTCOME; UNITED STATES;

EQUIPMENT DESIGN; HUMANS; LIVER FAILURE; OVERDOSE; SORPTION DETOXIFICATION;

EID: 10044293019     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000147959.42358.0B     Document Type: Conference Paper

References (37)

1. National Center for Health Statistics. Births, marriages, divorces, and deaths for 2002. National Vital Statistics Reports. 52: 13: 1-14, 2004.
2. Knell AJ, Dukes DC. Dialysis procedures in acute liver coma. Lancet, 2: 402-403, 1976.
3. Yamazaki F, Inoue N. Hepatic assist device, using membrane plasma separator and dialyzer. Med Prog Technol 12: 17-24, 1987.
4. Munoz JJ, Ballas SK, Moritz MJ, Martinez J, Friedman LS, Jarrell BE, et al. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. Transplant Proc 21: 3535-3536, 1989.
5. Lee C, Tink A. Exchange transfusion in hepatic coma: report of a case. Med J Aust 1: 40-42, 1958.
6. Trey MB, Burns DC, Saunders JJ. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 274: 473-481, 1966.
7. Winchester JF. Active methods of detoxification. In: Clinical Management of Poisoning and Drug Overdose, Haddad, LM, Winchester, JF (Eds), Second Edition, Haddad, LM, Winchester, JF (Eds), WB Saunders, Philadelphia 1990. p. 148.
8. Ellis AJ, O'Grady JG. Clinical disorders of renal function in acute liver failure, in Arroyo V, Gines P, Rodes J, Schrier RW, eds. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis and treatment. Blackwell Science, 1999, pp. 63-78.
9. Opolon P, Rapin JR, Huguet C, Granger A, Delome ML, Boschat M, at al. Hepatic failure coma (HFC) treated by polyacrylonitryle membrane (PAN) hemodialysis (HD). Trans Am Artif Intern Organs. 22: 701-709, 1976.
10. Schechter DC, Nealon TF, Gibbon JH. A simple extracorporeal device for reducing elevated blood ammonia levels. Surgery 44: 892-897, 1958.
11. Yatzidis H. A convenient hemoperfusion microapparatus over charcoal for the treatment of endogenous and exogenous intoxications: its use as an effective artificial kidney. Proc Eur Dial Transplant Assn 1: 83-87, 1964.
12. Ton HY, Hughes RD, Silk DBA, Williams R. Albumin coated Amberlite XAD-7 resin for Hemoperfusion in acute liver failure. Part I : Adsorption studies. Artif Organs 3: 20-22, 1979.
13. Hughes RD, Nagaki M, Keane H, Sheron N, Williams R. Artificial liver support in acute liver failure: A review of studies at King's. Artif Organs 16: 167-170, 1992.
14. Hillebrand DJ, Hill KB, Hu KQ, Strutt M, Wilson B, Cottrell A, Teichman S, Hay K, Bull B. Formal heparin anticoagulation protocol improves safety of charcoal-based liver assist treatments. ASAIO J, pending publication, 2004.
15. O'Grady JG, Gimson AE, O'Brien, CJ et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94: 1186, 1988.
16. Hughes RD, Nagaki M, Keane H, et al. Artificial liver support in acute liver failure: a review of studies at King's. Artif Organs 16: 167, 1992.
17. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Lorh M, Liebe S, Schareck W, Hopt UT, Schmidt R. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23: 319-330, 1999.
18. Mitzner SR, Stange J, Klammt S, Pexzynski P, Schmidt R, Noldge-Schomburg C. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 12: S75-S82, 2001.
19. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6: 287-289, 2000.
20. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D. J. Prometheus-a new extracorporeal system for the treatment of liver failure. Hepatol 39(6): 984-90, 2003.
21. Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R. Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device(FPSA-Prometheus). Wien Klin Wochenschr 115(15-16): 599-603, 2003.
22. Demetriou AA, Brown RS Jr., Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239(5): 660-7, 2004.
23. Arbios Systems, Inc. website: www.arbios.com, August, 2004.
24. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 337: 1112, 1997.
25. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 346: 547, 1995.
26. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 319: 1557, 1988.
27. Ash SR, Caldwell CA, Singer GG, et al. Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure by the BioLogic-DT system (abstract). Hepatology. 30: 552A, 1999.
28. Rumack BH, Peterson RG, Koch GG, Amara IA. Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 141: 380, 1981.
29. Ash SR, Blake DE, Carr DJ, et al. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs 15: 151, 1992.
30. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 18: 355, 1994.
31. Ash SR, Blake DE, Carr DJ, et al. Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis. ASAIO Trans 37: M332, 1991.
32. Ash SR. Powdered Sorbent liver dialysis and pheresis in treatment of hepatic failure. Therapeutic Apheresis 5(5): 404-416, 2001.
33. Ash SR. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Advances in Renal Replacement Therapy 9: 3-18, 2002.
34. Wilkinson AH, Ash SR, Nissenson AR. Hemodiabsorption in treatment of hepatic failure. J Transpl Coord. 8: 43, 1998. [Erratum is published in J Transpl Coord. 8(2): 73, 1998.]
35. Kramer L, Gendo A, Madl C, et al. A controlled study of the BioLogic-DT System in chronic hepatic encephalopathy (abstract). Hepatology. 28: 410A, 1998.
36. Ellis AJ, Hughes RD, Nicholl D, et al. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int J Artif Organs 22: 27, 1999.
37. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and Bioartificial support systems for acute and acute-on-chronic liver failure. JAMA. 289(2): 217-222, 2003.